Why this master of disguise needs careful handling

Dec 19, 2019

“NETs – Why this master of disguise needs careful handling”

A fantastic INCA inspired article in Cancer World. Sophie Fessl hears from patients and experts about why specialist NET services are so important. Great work to all other contributors.

Recent News

New Research Trial – The NELMAS trial

New Research Trial – The NELMAS trial

NELMAS - An international multi-centre, stratified, open, randomized, comparator-controlled, parallel-group phase II study comparing adjuvant treatment with 177Lu-DOTATATE (Lutathera®) to best supportive care in patients after resection of neuroendocrine liver...

read more